JP2019506390A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019506390A5 JP2019506390A5 JP2018537799A JP2018537799A JP2019506390A5 JP 2019506390 A5 JP2019506390 A5 JP 2019506390A5 JP 2018537799 A JP2018537799 A JP 2018537799A JP 2018537799 A JP2018537799 A JP 2018537799A JP 2019506390 A5 JP2019506390 A5 JP 2019506390A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- hapten
- class drug
- fentanyl class
- vivo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960005486 vaccines Drugs 0.000 claims 7
- PJMPHNIQZUBGLI-UHFFFAOYSA-N Fentanyl Chemical class C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 229940079593 drugs Drugs 0.000 claims 6
- 239000011324 bead Substances 0.000 claims 3
- 239000000969 carrier Substances 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- 108091003117 Bovine Serum Albumin Proteins 0.000 claims 2
- 229940098773 Bovine Serum Albumin Drugs 0.000 claims 2
- 102000004851 Immunoglobulin G Human genes 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229960000814 tetanus toxoid Drugs 0.000 claims 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims 1
- 102100000129 CHURC1 Human genes 0.000 claims 1
- 101710014631 CHURC1 Proteins 0.000 claims 1
- 206010012335 Dependence Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 231100000636 lethal dose Toxicity 0.000 claims 1
Claims (9)
- 請求項1記載の式(I)(ここで、Xはタンパク質担体またはアミノ官能基化ビーズを含み、該タンパク質または該ビーズは該ハプテンとアミド結合を形成する)の化合物を含む、フェンタニルクラス薬物に対するインビボ・イムノアンタゴニストをインビボで生成させるためのハプテンコンジュゲート。
- 該タンパク質担体がウシ血清アルブミン(BSA)または破傷風トキソイド(TT)である、請求項2記載のコンジュゲート。
- 該アミノ官能基化ビーズがDynabead M−270アミンである、請求項2記載のコンジュゲート。
- 請求項2記載のハプテンコンジュゲートの有効量を投与することにより哺乳動物において製造されるワクチン。
- 該ワクチンが、フェンタニルクラス薬物に特異的なIgG抗体を含む、請求項5記載のワクチン。
- 請求項5記載のワクチンを含む、患者における作用部位におけるフェンタニルクラス薬物の濃度を有効に最小にするための組成物。
- 該ワクチンの投与が、それ無しでは致死量となるフェンタニルクラス薬物からの有意な防御を患者にもたらす、請求項7記載の組成物。
- 患者への該ワクチンの投与がフェンタニルクラス薬物の嗜癖傾向および過剰摂取の可能性を低減する、請求項7記載の組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662281262P | 2016-01-21 | 2016-01-21 | |
US62/281,262 | 2016-01-21 | ||
PCT/US2017/013865 WO2017127390A1 (en) | 2016-01-21 | 2017-01-18 | Synthetic opioid vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019506390A JP2019506390A (ja) | 2019-03-07 |
JP2019506390A5 true JP2019506390A5 (ja) | 2020-02-27 |
Family
ID=59362842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018537799A Pending JP2019506390A (ja) | 2016-01-21 | 2017-01-18 | 合成オピオイドワクチン |
Country Status (8)
Country | Link |
---|---|
US (1) | US11305010B2 (ja) |
EP (1) | EP3405475B1 (ja) |
JP (1) | JP2019506390A (ja) |
CN (1) | CN108884127A (ja) |
BR (1) | BR112018014908A2 (ja) |
CA (1) | CA3015336A1 (ja) |
RU (1) | RU2018130106A (ja) |
WO (1) | WO2017127390A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11660331B2 (en) | 2017-11-09 | 2023-05-30 | The Scripps Research Institute | Heroin vaccine |
WO2020006563A1 (en) * | 2018-06-29 | 2020-01-02 | Marquette University | Fluorinated compounds as ph-sensitive analgesics |
EP4054571A4 (en) * | 2019-11-08 | 2024-01-10 | Regents of the University of Minnesota | FENTANYL HAPTEN, FENTANYL HAPTEN CONJUGATES AND METHOD FOR THE PRODUCTION AND USE THEREOF |
US20230100186A1 (en) * | 2020-01-13 | 2023-03-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Fentanyl haptens for the preparation of a fentanyl vaccine |
CA3175295A1 (en) * | 2020-03-13 | 2021-09-16 | Regents Of The University Of Minnesota | Fentanyl haptens, fentanyl hapten conjugates, and methods for making and using |
WO2022240898A1 (en) * | 2021-05-10 | 2022-11-17 | Cornell University | Development of a highly efficient second generation fentanyl-conjugate vaccine to treat fentanyl addiction |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5283066A (en) * | 1992-02-19 | 1994-02-01 | Development Center For Biotechnology | Method of stimulating an immune response by using a hapten |
JPH07505634A (ja) | 1992-04-06 | 1995-06-22 | バイオサイト・ダイアグノスティックス・インコーポレイテッド | 新規オピエート誘導体,タンパクおよびポリペプチドオピエート誘導共役体および標識 |
US6262265B1 (en) | 1999-06-18 | 2001-07-17 | Microgenics Corporation | Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay |
CN100402084C (zh) | 2001-11-16 | 2008-07-16 | 兰多克斯实验室有限公司 | 检测或定量芬太尼或其类似物的代谢物的方法和试剂盒 |
RU2326693C2 (ru) * | 2002-07-18 | 2008-06-20 | Цитос Байотекнолоджи Аг | Конъюгаты гаптен-носитель и их применение |
WO2004111202A2 (en) * | 2003-03-07 | 2004-12-23 | Incyte Corporation | Neurotransmission-association proteins |
MXPA04006617A (es) | 2004-07-07 | 2006-01-12 | Inst Nac De Psiquiatria Ramon | Proceso para la preparacion y uso de una vacuna bivalente contra la adiccion a la morfina-heroina. |
CA2930677A1 (en) * | 2005-02-08 | 2006-08-17 | Genzyme Corporation | Antibodies to tgfbeta |
US20110182918A1 (en) * | 2008-06-13 | 2011-07-28 | Nabi Biopharmaceuticals | Personalized drug treatment and smoking cessation kit and method |
KR101047192B1 (ko) * | 2009-04-15 | 2011-07-06 | 포항공과대학교 산학협력단 | 표적 특이적 비항체 단백질 및 이의 제조 방법 |
AU2011329647B2 (en) * | 2010-11-19 | 2015-10-22 | Eisai R&D Management Co., Ltd. | Neutralizing anti-CCL20 antibodies |
US9702869B2 (en) * | 2011-11-30 | 2017-07-11 | Defined Diagnostics, Llc | Assays, antibodies, immunogens and compositions related to 5-FU |
US20150343054A1 (en) | 2011-12-21 | 2015-12-03 | Kim D. Janda | Heroin Haptens, Immunoconjugates and Related Uses |
US20140093525A1 (en) * | 2012-09-17 | 2014-04-03 | Minneapolis Medical Research Foundation | Compositions and methods of treating opioid addiction |
US9981043B2 (en) | 2013-02-08 | 2018-05-29 | Regents Of The University Of Minnesota | Analgesic conjugates |
US9213029B2 (en) * | 2013-06-25 | 2015-12-15 | Samsung Electronics Co., Ltd. | Method for diagnosing breast cancer by detection of polymeric immunoglobulin receptor in vesicles isolated from patients |
-
2017
- 2017-01-18 RU RU2018130106A patent/RU2018130106A/ru unknown
- 2017-01-18 CN CN201780007832.8A patent/CN108884127A/zh active Pending
- 2017-01-18 BR BR112018014908-0A patent/BR112018014908A2/pt not_active Application Discontinuation
- 2017-01-18 US US16/071,199 patent/US11305010B2/en active Active
- 2017-01-18 WO PCT/US2017/013865 patent/WO2017127390A1/en active Application Filing
- 2017-01-18 CA CA3015336A patent/CA3015336A1/en active Pending
- 2017-01-18 EP EP17741829.0A patent/EP3405475B1/en active Active
- 2017-01-18 JP JP2018537799A patent/JP2019506390A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2019506390A5 (ja) | ||
RU2018130106A (ru) | Вакцина против синтетических опиоидов | |
Sulczewski et al. | Nanoparticle vaccines against viral infections | |
JP2016516074A5 (ja) | ||
JP2014513725A5 (ja) | ||
JP2014515406A5 (ja) | ||
JP2013517277A5 (ja) | ||
JP2019500327A5 (ja) | ||
RU2014141545A (ru) | Нацеливающие аминокислотные липиды | |
JP2012017342A5 (ja) | ||
JP2006527762A5 (ja) | ||
JP2013534248A5 (ja) | ||
JP2012522802A5 (ja) | ||
JP2013231081A5 (ja) | ||
CU23917B1 (es) | Proceso para la preparación y uso de una vacuna bivalente contra la adicción a la morfina-heroína | |
TWI578997B (zh) | 用於預防或治療菸鹼成癮之共軛體 | |
JP2018505882A5 (ja) | ||
JP2019536761A5 (ja) | ||
JP2016531895A5 (ja) | ||
JP2018039839A (ja) | 不活化全粒子ワクチンを含有するマイクロニードルアレイ製剤およびその投与方法 | |
RU2014151567A (ru) | Конъюгат менингококка серогруппы х | |
EA201171032A1 (ru) | Схемы лечения с помощью вакцины против гриппа, связанного с пандемическими штаммами | |
CY1120852T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ιβουπροφαινη, τραμαδολη και ενα βασικο αμινοξυ, μεθοδος παρασκευης αυτης και χρηση της ιδιας | |
ES2565578T3 (es) | Vacunas contra el cáncer que contienen epítopos de antígeno oncofetal | |
JP2012519724A5 (ja) |